Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reward mechanisms and motivational symptoms in Parkinson's disease
NL-OMON27566Recruiting
- Sponsor
- Maastricht University
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate and pramipexole in Parkinson's disease (PD) (3 arms), sponsored by Maastricht University. Primary endpoints: Neuropsychiatric and neuropsychological test performance, Cognitive status assessment and 3 more. Started Dec 2007; status: recruiting.
02
Drugs
methylphenidatepramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON27566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27566.